In vitro activities of azithromycin (CP 62,993), clarithromycin (A-56268; TE-031), erythromycin, roxithromycin, and clindamycin
about
Effect of pH on the in vitro potency of clarithromycin against Mycobacterium avium complexEffect of CO2 on susceptibilities of anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycin.A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis.Evaluation of antimicrobial activities of clarithromycin and 14-hydroxyclarithromycin against three strains of Haemophilus influenzae by using an in vitro pharmacodynamic model.The macrolides.Concentration of azithromycin in human prostatic tissue.Safety, toleration, and pharmacokinetics of intravenous azithromycinAzithromycin: the first azalide antibiotic.Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides.In vitro and in vivo activities of macrolides against Mycobacterium lepraeActivities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organismsIn vitro activity of azithromycin compared with that of erythromycin against Actinobacillus actinomycetemcomitans.Erythromycin, clarithromycin, and azithromycin: use of frequency distribution curves, scattergrams, and regression analyses to compare in vitro activities and describe cross-resistance.Current use of anti-infectives in dermatology.Evaluation of in vitro spectra of activity of azithromycin, clarithromycin, and erythromycin tested against strains of Neisseria gonorrhoeae by reference agar dilution, disk diffusion, and Etest methods.Azithromycin: single 1.5 g dose in the treatment of patients with atypical pneumonia syndrome--a randomized study.The macrolide antibiotic renaissance.Antimicrobial activities and postantibiotic effects of clarithromycin, 14-hydroxy-clarithromycin, and azithromycin in epithelial cell lining fluid against clinical isolates of haemophilus influenzae and Streptococcus pneumoniaeActivities of beta-lactams and macrolides against Helicobacter pylori.Potentiation of antibacterial activity of azithromycin and other macrolides by normal human serum.Activities of clarithromycin against eight slowly growing species of nontuberculous mycobacteria, determined by using a broth microdilution MIC system.Efficacy of azithromycin in reducing lower genital Ureaplasma urealyticum colonization in women at risk for preterm delivery.Incidence and susceptibility to antimicrobial agents of Listeria spp. and Listeria monocytogenes isolated from poultry carcasses in Porto, Portugal.Clarithromycin in the treatment of skin and skin structure infections: two multicenter clinical studies. Clarithromycin Study Group.Ocular pharmacokinetic study following single and multiple azithromycin administrations in pigmented rabbits.Quality control parameters and interpretive criteria for in vitro susceptibility tests with the macrolide azithromycin. Collaborative Antimicrobial Susceptibility Testing Group.Effects of environmental factors on the in vitro potency of azithromycin.The antimicrobial susceptibility of Mycobacterium chelonae isolated from corneal ulcer
P2860
Q28326618-DDAC26C0-C714-4700-AE3F-A3CA8AFA6DD3Q33748441-4BFBEF4B-8E48-4812-BAF0-34D13146A81DQ33750614-C9BEC384-3348-4882-8428-803A77C9F9BBQ33758174-FC7C9EA8-8EF7-471E-A706-DCBC43F79C25Q34519125-B82DB60F-7686-4ED9-B573-7AF263A7E2B2Q34602182-5882C019-9DE5-483A-B66F-DD34B035E38BQ35129291-D8A591E8-3C01-41FB-B8E3-67086020615DQ35234822-3803FD11-B6D6-436D-A51F-7998650E4F0CQ35564733-99E66D00-725A-4597-873D-D1006945B4B8Q35565659-CAF88C71-2E71-482F-839B-49ACAC45A61FQ35843595-F36BAA13-8087-4C1A-8185-B1E7402F6B1FQ35862665-782F1B05-0779-48D0-A1B1-E9F56AF47495Q35897251-5574F717-287F-4059-B1B2-C3BF971209EBQ36233506-C40FBE1C-B858-4198-8DEB-043E57721D4AQ36527995-302635B6-D239-4E51-9FC9-AEDE3A17D8CBQ37878203-87E0052B-8D3C-4F2F-9AED-229600E58FDBQ39406507-EBD0A1A3-0354-4C14-A8C5-EB81E2D760BAQ39470774-D8783A2A-36E1-4EB3-B9D2-6AAF7C207A30Q39470898-C68A09E6-1AE1-4FDB-B4CC-C090AE6326DCQ39870885-952A883F-6D78-4524-A251-0989CFE01444Q39881867-88B9A4E2-75EC-4C02-A5E4-930765308EE4Q41610620-29280D63-88D3-4315-86F9-629F14329B3DQ44258145-6D7E5655-CF44-4F58-900F-9C2CE0DE03A8Q44915723-7FFECD07-BF1C-465B-84F5-EFE4D9672291Q46739183-ED15375D-9208-4544-920D-754516097636Q54352831-CA1E6518-B8FE-405F-B9D6-53D55FA9DEA9Q54691340-F891E5A6-C712-4619-84FD-1FF0C939AA10Q58815580-124BCD1C-60B6-4CAA-9B00-387D68CE937D
P2860
In vitro activities of azithromycin (CP 62,993), clarithromycin (A-56268; TE-031), erythromycin, roxithromycin, and clindamycin
description
1988 nî lūn-bûn
@nan
1988 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
In vitro activities of azithro ...... roxithromycin, and clindamycin
@ast
In vitro activities of azithro ...... roxithromycin, and clindamycin
@en
type
label
In vitro activities of azithro ...... roxithromycin, and clindamycin
@ast
In vitro activities of azithro ...... roxithromycin, and clindamycin
@en
prefLabel
In vitro activities of azithro ...... roxithromycin, and clindamycin
@ast
In vitro activities of azithro ...... roxithromycin, and clindamycin
@en
P2093
P2860
P356
P1476
In vitro activities of azithro ...... roxithromycin, and clindamycin
@en
P2093
P2860
P304
P356
10.1128/AAC.32.5.752
P407
P577
1988-05-01T00:00:00Z